<DOC>
	<DOCNO>NCT01565889</DOCNO>
	<brief_summary>This study consist 2 part , Part A Part B . Part A , Phase 1 drug interaction/early viral kinetic study , evaluate effect select antiretroviral therapy safety , viral kinetics , pharmacokinetics sofosbuvir ( GS-7977 ; PSI-7977 ) metabolites participant HIV hepatitis C virus ( HCV ) coinfection . Part B , Phase 2 treatment study , investigate efficacy safety sofosbuvir , pegylated interferon alpha ( PEG ) ribavirin ( RBV ) participant HIV/HCV coinfection .</brief_summary>
	<brief_title>Part A : Drug Interaction Study Sofosbuvir Antiretroviral Therapy ( ART ) Combinations HIV Hepatitis C Virus ( HCV ) Co-infected Patients . Part B : Efficacy Safety Sofosbuvir 12 Weeks HIV/HCV Co-infected Patients .</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Darunavir</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>Healthy accord medical history physical examination exception HCV HIV diagnose Confirmation Chronic HCV infection Confirmation Chronic HIV1 infection On stable protocol approve HIV antiretroviral ( ARV ) regimen undetectable HIVRNA Agree use two form highly effective contraception duration study 6 month last dose study medication Subjects must naive treatment chronic HCV infection Known suspect cirrhosis History clinically significant chronic liver disease A history consistent decompensated liver disease . Use prohibit medication define protocol Pregnant nursing female male pregnant female partner Contraindication PEG RBV therapy ( Part B ) Clinically relevant drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>